Atlas Trials

Study to Explore the Safety and Efficacy of NT-0796 as an Adjunct to Semaglutide in Participants With Obesity (RESOLVE-2)

Clinical trial NCT07220629 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT07220629
Sponsor
NodThera Limited
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Obesity
Start date
2025-10-02
Primary completion
2026-08-21
Enrollment
82

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.